Navigation Links
Some Antibiotics, Blood Pressure Meds a Bad Mix: Study
Date:1/17/2011

By Steven Reinberg
HealthDay Reporter

MONDAY, Jan. 17 (HealthDay News) -- Older people who are taking common blood pressure medications called calcium channel blockers face an increased risk of developing dangerously low blood pressure and possibly going into shock if they take certain antibiotics, Canadian researchers warn.

"Two common antibiotics, erythromycin and clarithromycin, if given to patients taking calcium channel blockers, can increase the risk substantially of being hospitalized for low blood pressure," said lead researcher Dr. David Juurlink, a scientist at Sunnybrook Research Institute in Toronto.

For patients taking erythromycin along with a calcium channel blocker the risk goes up almost sixfold, while it increases almost fourfold for patients taking clarithromycin, he said.

Although the interaction between these drugs has been known for some 20 years, this is the first time the risk has been quantified, Juurlink said.

Juurlink noted a cousin of these drugs, azithromycin, doesn't cause this problem. "One of the main suggestions of the study is, if you are on a calcium channel blocker and you need to go on an antibiotic in this class, azithromycin is a safer one to use," he said.

The report is published in the Jan. 17 edition of the Canadian Medical Association Journal.

For the study, Juurlink's team collected data on people aged 66 and older who were taking calcium channel blockers between 1994 and 2009.

The researchers sorted out who among these patients was hospitalized for low blood pressure (hypotension) and whether or not they had taken a macrolide antibiotic before being hospitalized.

Juurlink's group found that 7,100 of these patients had been hospitalized for low blood pressure or shock, and that having taken either erythromycin or clarithromycin was associated with an increased risk of trouble.

The reason these antibiotics have this effect is that they interfere with an enzyme in the liver that is needed to break down the calcium channel blocker. When this enzyme is "turned off," too much of the calcium blocker accumulates and causes blood pressure to drop dangerously low, Juurlink explained.

Dr. Barry J. Materson, a professor of medicine at the University of Miami Miller School of Medicine and a specialist in blood pressure, said that this study "is of practical interest."

The researchers have established that the combination of a macrolide antibiotic and a calcium channel blocker can cause hypotension or even shock because of increased blood levels of the calcium channel blocker, Materson said.

"This happens because of the interference with an enzyme that metabolizes the calcium blocker," Materson noted.

Materson added that grapefruit juice can also interfere with the same enzyme and lead to elevated levels of calcium channel blockers. "Grapefruit juice is consumed much more frequently than macrolide antimicrobials," he pointed out.

One limitation of the study is not knowing how many of these patients had hypotension or shock from the infection for which they were receiving the antibiotic. "We also do not know how many, if any, consume grapefruit juice," Materson said.

"Nevertheless, it is important for practitioners, pharmacists and patients to appreciate that both grapefruit juice and macrolide antibiotics, with the possible exception of azithromycin, can increase the blood level of the calcium channel blockers to an unpredictable degree and may rarely result in hypotension or even shock," he said.

More information

For more information on drug interactions, visit the U.S. Food and Drug Administration.

SOURCES: David Juurlink, M.D., Ph.D., scientist, Sunnybrook Research Institute, Toronto; Barry J. Materson, M.D., professor, medicine, University of Miami Miller School of Medicine; Jan. 17, 2011, Canadian Medical Association Journal


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Smarten Up About Antibiotics, CDC Urges
2. Blood Type O Associated With Less Risk for Heart Attack
3. Bioactive compounds in berries can reduce high blood pressure
4. Room light before bedtime may impact sleep quality, blood pressure and diabetes risk
5. International research team reports major findings in prevention and treatment of blood clots
6. UNC researchers inch closer to unlocking potential of synthetic blood
7. Secondhand Smoke Tied to High Blood Pressure in Kids
8. Embryonic stem cells help deliver good genes in a model of inherited blood disorder
9. Immune Disorders May Raise Blood Clot Risk in Hospitalized Patients
10. Engineering team invents lab-on-a-chip for fast, inexpensive blood tests
11. Early Steps Toward an Alzheimers Blood Test
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Some Antibiotics, Blood Pressure Meds a Bad Mix: Study
(Date:2/10/2016)... ... 10, 2016 , ... As part of its ongoing series of aquatic therapy ... webinar features a dynamic expert and thoughtful presentation to give attendees a better sense ... Both events are free to attend, but registration is required. , Rehabilitation ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... American Academy of Emergency Medicine , an emergency medicine professional association, ... practice management services . , The American Academy of Emergency Medicine, or AAEM, ...
(Date:2/10/2016)... ... February 10, 2016 , ... The Wickman Agency ... to assist the local community. Pledging to select a new beneficiary every 60 ... the area. Their goal is to bring community awareness to important local causes ...
(Date:2/10/2016)... ... February 10, 2016 , ... 10 Best Water ... three leading bottled water brand owners that topped the list as a result of ... optimize conversion. The premier brand was Tibet 5100, a top notch water company that ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... Dr. Jessica ... the practice is now accepting new dental patients and families in the North Metro ... dental care services from cleanings to cosmetic dentistry, and all in the most relaxing ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, LLC, ... new approaches to the treatment of lupus and ... a multiple ascending dose study in patients with ... RSLV-132. --> --> ... multiple ascending dose study of RSLV-132 in 32 ...
(Date:2/10/2016)... Urologix, the market leader for in-office minimally ... Hyperplasia (BPH), announces new private ownership and is operating ... device industry veteran of more than 20 years, has ... Plymouth, Minn. The company,s ... Prostiva® RF Therapy, will continue to be broadly available ...
(Date:2/10/2016)... -- Astellas Pharma Inc. (TSE: 4503, President and CEO: ... successfully completed, through its indirect wholly-owned subsidiary Laurel Acquisition ... and outstanding shares of common stock of Ocata Therapeutics, ... , "Ocata") for a price of US$8.50 per share ... commenced the Tender Offer on November 19, 2015, U.S. ...
Breaking Medicine Technology: